USING ISOTRETINOIN AND PHOSPHODIESTERASE-5 INHIBITORS TO ENHANCE THE ANTITUMOR IMMUNE RESPONSE AND IMMUNOTHERAPY FOR LUNG CANCER
$155,000FY2020Defense Health AgencyDOD
University Of Missouri System, Columbia MO
University Of Missouri System, Columbia MO